Matches in SemOpenAlex for { <https://semopenalex.org/work/W4256694012> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4256694012 endingPage "4676" @default.
- W4256694012 startingPage "4676" @default.
- W4256694012 abstract "4676 Background: In the preliminary non-randomized study, combination therapy with natural IFN plus cimetidine showed high response rate in 15 out of 37 patients (41%) for advanced renal cell carcinoma. A prospective randomized multiinstitutional clinical trial to compare the effect of IFN alone to IFN + cimetidine in patients with advanced renal cell carcinoma with pulmonary metastasis was performed. Methods: Patients received IFN (5 megaunits) 5 times a week, or the IFN regimen plus daily oral cimetidine (800 mg). The primary end point was response rate, and time to progression (TTP). The secondary end point was overall survival. Results: Between April 1998 and March 2002, 71 patients from 32 institutions were randomly assigned to the two treatment groups. One patient in each group was found to be ineligible because they did not receive IFN at all. Two patients in IFN alone group stopped the treatment on day 9 and on day 10. Among 36 patients in IFN alone group, one CR, 4 PRs, 16 NCs, and 12 PDs were shown, with a response rate of 15.2%. Of 35 patients in IFN + cimetidine group, two CRs, 8 PRs, 13 NCs, and 11 PDs were observed, with a response rate of 29.4%. The difference was not significant (P=0.34). TTP ranged from 9 to 2307 days (median 179 days) in the IFN alone group, and from 31 to 3030 days (median 178 days) in IFN plus cimetidine group (p=0.86). The overall survival between the two groups was not significantly different either. The responses in pulmonary site were 1 CR, 3 PRs, 20 NCs, and 9 PDs in the IFN alone group, and 2 CRs, 7 PRs, 17 NCs, and 7 PDs in the combination therapy group (P=0.13). Conclusions: The combined treatment with IFN + cimetidine for advanced renal cell carcinoma could not have shown significant improvement in response rates or survival compared to IFN alone therapy. No significant financial relationships to disclose." @default.
- W4256694012 created "2022-05-12" @default.
- W4256694012 creator A5000547449 @default.
- W4256694012 creator A5004687590 @default.
- W4256694012 creator A5014449911 @default.
- W4256694012 creator A5020661488 @default.
- W4256694012 creator A5043058133 @default.
- W4256694012 creator A5062792817 @default.
- W4256694012 creator A5075379782 @default.
- W4256694012 creator A5083135263 @default.
- W4256694012 creator A5091294460 @default.
- W4256694012 date "2004-07-15" @default.
- W4256694012 modified "2023-09-27" @default.
- W4256694012 title "Prospective randomized trial of natural interferon-alpha (IFN) versus IFN + cimetidine in advanced renal cell carcinoma with pulmonary metastasis" @default.
- W4256694012 doi "https://doi.org/10.1200/jco.2004.22.14_suppl.4676" @default.
- W4256694012 hasPublicationYear "2004" @default.
- W4256694012 type Work @default.
- W4256694012 citedByCount "0" @default.
- W4256694012 crossrefType "journal-article" @default.
- W4256694012 hasAuthorship W4256694012A5000547449 @default.
- W4256694012 hasAuthorship W4256694012A5004687590 @default.
- W4256694012 hasAuthorship W4256694012A5014449911 @default.
- W4256694012 hasAuthorship W4256694012A5020661488 @default.
- W4256694012 hasAuthorship W4256694012A5043058133 @default.
- W4256694012 hasAuthorship W4256694012A5062792817 @default.
- W4256694012 hasAuthorship W4256694012A5075379782 @default.
- W4256694012 hasAuthorship W4256694012A5083135263 @default.
- W4256694012 hasAuthorship W4256694012A5091294460 @default.
- W4256694012 hasConcept C121608353 @default.
- W4256694012 hasConcept C126322002 @default.
- W4256694012 hasConcept C141071460 @default.
- W4256694012 hasConcept C168563851 @default.
- W4256694012 hasConcept C188816634 @default.
- W4256694012 hasConcept C203014093 @default.
- W4256694012 hasConcept C203092338 @default.
- W4256694012 hasConcept C2776178377 @default.
- W4256694012 hasConcept C2777472916 @default.
- W4256694012 hasConcept C2779013556 @default.
- W4256694012 hasConcept C2780719153 @default.
- W4256694012 hasConcept C2781413609 @default.
- W4256694012 hasConcept C2909179924 @default.
- W4256694012 hasConcept C71924100 @default.
- W4256694012 hasConcept C90924648 @default.
- W4256694012 hasConceptScore W4256694012C121608353 @default.
- W4256694012 hasConceptScore W4256694012C126322002 @default.
- W4256694012 hasConceptScore W4256694012C141071460 @default.
- W4256694012 hasConceptScore W4256694012C168563851 @default.
- W4256694012 hasConceptScore W4256694012C188816634 @default.
- W4256694012 hasConceptScore W4256694012C203014093 @default.
- W4256694012 hasConceptScore W4256694012C203092338 @default.
- W4256694012 hasConceptScore W4256694012C2776178377 @default.
- W4256694012 hasConceptScore W4256694012C2777472916 @default.
- W4256694012 hasConceptScore W4256694012C2779013556 @default.
- W4256694012 hasConceptScore W4256694012C2780719153 @default.
- W4256694012 hasConceptScore W4256694012C2781413609 @default.
- W4256694012 hasConceptScore W4256694012C2909179924 @default.
- W4256694012 hasConceptScore W4256694012C71924100 @default.
- W4256694012 hasConceptScore W4256694012C90924648 @default.
- W4256694012 hasIssue "14_suppl" @default.
- W4256694012 hasLocation W42566940121 @default.
- W4256694012 hasOpenAccess W4256694012 @default.
- W4256694012 hasPrimaryLocation W42566940121 @default.
- W4256694012 hasRelatedWork W1212782987 @default.
- W4256694012 hasRelatedWork W1550484024 @default.
- W4256694012 hasRelatedWork W156517894 @default.
- W4256694012 hasRelatedWork W1854126421 @default.
- W4256694012 hasRelatedWork W1995490256 @default.
- W4256694012 hasRelatedWork W2113493650 @default.
- W4256694012 hasRelatedWork W2122157810 @default.
- W4256694012 hasRelatedWork W2226617841 @default.
- W4256694012 hasRelatedWork W2409509982 @default.
- W4256694012 hasRelatedWork W2414867669 @default.
- W4256694012 hasVolume "22" @default.
- W4256694012 isParatext "false" @default.
- W4256694012 isRetracted "false" @default.
- W4256694012 workType "article" @default.